| Home > Publications Database > SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study. > Access to Fulltext |
DZNE-2026-00337
|
|||||||
| version 1 |
| ||||||
| Restricted | ||||
DZNE-2026-00337 SUP
|
||||
| version 1 |
| |||